Loading clinical trials...
Loading clinical trials...
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Baylor Research Institute
Collaborators
NCT07129590 · Smoking Cessation, Tobacco Smoking, and more
NCT07292883 · Tobacco Use Disorder, Addiction Nicotine
NCT07466875 · Nicotine Dependence, Nicotine Withdrawal, and more
NCT06218056 · Tobacco Use Disorder, Tobacco Smoking, and more
NCT06372899 · E-cigarette Use, Cigarette Smoking, and more
Baylor Scott and White Community Care
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions